Adaptive Pharmacotherapy for Smoking Cessation
A randomized, controlled trial of adaptive pharmacotherapy for smoking cessation shows quit rates nearly three times the standard treatment.
Balance Is Key
Potential miracle is that GLP-1 drugs ease withdrawal symptoms. Even setting aside the illegal addictive substances and considering only nicotine and alcohol, it would seem like a golden opportunity.
Semaglutide As Potential Addiction Therapy
Recently, there has been growing interest in another possible use for GLP-1 weight loss and diabetes drugs — to treat addiction.
Telehealth Company, Pelago, Raises Additional $58 Million in Venture Capital Funding
Virtual clinic, Pelago, raises $58 million for expansion in remote delivery of substance use disorder treatment.
National Institutes of Health Funds Drug Development to Treat Nicotine Addiction
The National Institutes of Health (NIH) and the National Institute on Drug Addiction (NIDA) announce funding for SBP-9330, a nicotine addiction treatment.
Cytisine – Made From Natural Products – Approved for Treatment of Nicotine Addiction
A drug derived from poisonous laburnum seeds, cytisine has been approved as a stop-smoking aid and shows promise for treating other addictions.